Health care fraud enforcement remains a top priority of the Trump administration, warns a law firm specializing in False ...
AI’s Emerging Role in Healthcare Artificial intelligence is significantly reshaping healthcare as more advanced machine learning algorithms and foundation models become available. It’s impacting ...
Since implementing the Health Home program, New York has witnessed marked performance improvements for numerous HEDIS processes-of-care measures for Health Home enrollees and at least a 25% reduction ...
What baseline measures can senior care organizations take to improve data security? Industry leaders share their perspectives ...
The specialty pharmacy industry is in a state of transformation, fueled by the rise of complex, innovative therapies and the ...
Clinician-Identified Health Characteristics and Palliative Care Eligibility: Is Dementia Overlooked?
Conclusions: There is a potential mismatch between what clinicians identify as important in determining palliative care need and final eligibility determinations. Patients with dementia were less ...
Comparable long-term effectiveness to standard of care corticosteroids over 5 years Normal growth maintained, in contrast to growth suppression commonly seen with standard of care corticosteroids ...
AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical,” or the “Company”), a leading therapeutic acute wound care company, today announced two podium presentations at the 2025 Southern Region ...
The amount New York receives will likely depend in part on whether the state implements policies pushed by the Trump administration.
Instead of seeking to replace whole systems, Paili focused on targeted interventions. His project, AIRA, an AI-powered knowledge assistant created with LangChain and Streamlit, won first place and a ...
Artificial intelligence (AI) is rapidly emerging as a transformative force in global health. From forecasting outbreaks,1 ...
At a time when large-scale human genome analysis was not yet common, the Tohoku Medical Megabank Organization (ToMMo) launched its genome cohort study. After 10 years of operating this ambitious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback